Pharma BD Deal Intelligence

AbbVie Inc. / Aliada Therapeutics

2024 · Acquisition/Merger · $1.4B · Complete

Announcement Sentiment

92

Strongly positive

Outcome Score

52

Mixed — partial payoff, real shortfalls.

AbbVie acquired Aliada Therapeutics for $1.4B for neuroscience pipeline.

Key facts

Announced Oct 28, 2024
Closed Dec 11, 2024
Deal value $1.4B
Deal type Acquisition/Merger
Therapeutic area Neurology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals